Miki Katoh

3.0k total citations
86 papers, 2.5k citations indexed

About

Miki Katoh is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Miki Katoh has authored 86 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pharmacology, 38 papers in Oncology and 28 papers in Molecular Biology. Recurrent topics in Miki Katoh's work include Pharmacogenetics and Drug Metabolism (46 papers), Drug Transport and Resistance Mechanisms (30 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Miki Katoh is often cited by papers focused on Pharmacogenetics and Drug Metabolism (46 papers), Drug Transport and Resistance Mechanisms (30 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Miki Katoh collaborates with scholars based in Japan, United States and Australia. Miki Katoh's co-authors include Tsuyoshi Yokoi, Miki Nakajima, Hiroshi Yamazaki, Hiroyuki Yamanaka, Chise Tateno, Katsutoshi Yoshizato, Masayuki Nadai, Tatsuki Fukami, Sumie Yoshitomi and Toshiyuki Takeuchi and has published in prestigious journals such as Journal of Biological Chemistry, International Journal of Cancer and Biochemical Pharmacology.

In The Last Decade

Miki Katoh

85 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miki Katoh Japan 31 1.2k 949 827 469 247 86 2.5k
J. Andrew Williams United States 21 1.6k 1.3× 1.1k 1.2× 679 0.8× 440 0.9× 224 0.9× 31 2.6k
Chuang Lu United States 23 1.1k 0.9× 748 0.8× 659 0.8× 250 0.5× 228 0.9× 56 2.3k
A. David Rodrigues United States 33 1.8k 1.5× 1.1k 1.2× 619 0.7× 362 0.8× 406 1.6× 68 3.0k
Jean‐Charles Gautier France 27 1.2k 1.1× 646 0.7× 852 1.0× 209 0.4× 239 1.0× 60 2.8k
Su Duan United States 26 1.6k 1.3× 761 0.8× 534 0.6× 531 1.1× 458 1.9× 43 2.9k
Kazuhide Iwasaki Japan 26 931 0.8× 683 0.7× 502 0.6× 415 0.9× 134 0.5× 68 2.0k
Michael Sinz United States 29 1.6k 1.4× 1.1k 1.1× 636 0.8× 394 0.8× 201 0.8× 72 2.8k
Zhi‐Rong Tan China 31 1.2k 1.0× 704 0.7× 774 0.9× 372 0.8× 412 1.7× 103 2.8k
Brahim Achour United Kingdom 25 938 0.8× 903 1.0× 560 0.7× 371 0.8× 150 0.6× 67 2.0k
Lydiane Pichard France 18 1.3k 1.1× 808 0.9× 450 0.5× 323 0.7× 191 0.8× 33 2.2k

Countries citing papers authored by Miki Katoh

Since Specialization
Citations

This map shows the geographic impact of Miki Katoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miki Katoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miki Katoh more than expected).

Fields of papers citing papers by Miki Katoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miki Katoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miki Katoh. The network helps show where Miki Katoh may publish in the future.

Co-authorship network of co-authors of Miki Katoh

This figure shows the co-authorship network connecting the top 25 collaborators of Miki Katoh. A scholar is included among the top collaborators of Miki Katoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miki Katoh. Miki Katoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nadai, Masayuki, et al.. (2021). Species differences in oxidative metabolism of regorafenib. Xenobiotica. 51(12). 1400–1407. 3 indexed citations
2.
Asai, Yuki, et al.. (2018). Effect of single‐walled carbon nanotubes on cytochrome P450 activity in human liver microsomes in vitro. Biopharmaceutics & Drug Disposition. 39(5). 275–279. 2 indexed citations
3.
Asai, Yuki, et al.. (2017). Status Epilepticus Decreases Brain Cytochrome P450 2D4 Expression in Rats. Journal of Pharmaceutical Sciences. 107(4). 975–978. 5 indexed citations
4.
Katoh, Miki, et al.. (2015). Species and tissue differences in serotonin glucuronidation. Xenobiotica. 46(7). 605–611. 22 indexed citations
5.
Katoh, Miki, et al.. (2015). Effects of Phenobarbital on Expression of UDP-Glucuronosyltransferase 1a6 and 1a7 in Rat Brain. Drug Metabolism and Disposition. 44(3). 370–377. 14 indexed citations
6.
Katoh, Miki, et al.. (2011). Changes in Expression of Drug-Metabolizing Enzymes by Single-Walled Carbon Nanotubes in Human Respiratory Tract Cells. Drug Metabolism and Disposition. 40(3). 579–587. 12 indexed citations
7.
Noda, Takayuki, Fumie Abe, Miki Kato, et al.. (2010). Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats. Journal of Infection and Chemotherapy. 17(2). 207–213. 2 indexed citations
8.
Katoh, Miki, et al.. (2009). Inhibitory Effects of Kampo Medicine on Human UGT2B7 Activity. Drug Metabolism and Pharmacokinetics. 24(6). 490–499. 9 indexed citations
9.
Katoh, Miki, Takeshi Sawada, Mitsutoshi Nakajima, et al.. (2007). Humanization of Excretory Pathway in Chimeric Mice with Humanized Liver. Toxicological Sciences. 97(2). 533–538. 56 indexed citations
10.
Higashi, Eriko, Miki Nakajima, Miki Katoh, Shogo Tokudome, & Tsuyoshi Yokoi. (2007). Inhibitory Effects of Neurotransmitters and Steroids on Human CYP2A6. Drug Metabolism and Disposition. 35(4). 508–514. 20 indexed citations
11.
Katoh, Miki, Yoshinori Soeno, Miki Nakajima, et al.. (2006). In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver. Journal of Pharmaceutical Sciences. 96(2). 428–437. 68 indexed citations
12.
Fukami, Tatsuki, Miki Nakajima, Haruko SAKAI, Miki Katoh, & Tsuyoshi Yokoi. (2006). CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline. Drug Metabolism and Disposition. 35(3). 335–339. 37 indexed citations
13.
Nakajima, Miki, Yuki Tsuchiya, Miki Katoh, et al.. (2006). Decreased responsiveness of naturally occurring mutants of human estrogen receptor α to estrogens and antiestrogens. The Journal of Steroid Biochemistry and Molecular Biology. 100(1-3). 79–86. 7 indexed citations
14.
Katoh, Miki, M. Watanabe, Yasushi Sato, et al.. (2005). In vivoinduction of human cytochrome P450 3A4 by rifabutin in chimeric mice with humanized liver. Xenobiotica. 35(9). 863–875. 32 indexed citations
15.
Maniratanachote, Rawiwan, et al.. (2005). Simultaneous measurement of gene expression for hepatotoxicity in thioacetamide-administered rats by DNA microarrays. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 603(1). 64–73. 7 indexed citations
16.
Takemoto, Kei, Miki Nakajima, Yuto Fujiki, et al.. (2004). Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo- p -dioxin. Archives of Toxicology. 78(6). 309–315. 21 indexed citations
17.
Yamanaka, Hiroyuki, Miki Nakajima, Miki Katoh, et al.. (2004). TRANS-3′-HYDROXYCOTININE O- AND N-GLUCURONIDATIONS IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 33(1). 23–30. 51 indexed citations
18.
Katoh, Miki, et al.. (2004). IDENTIFICATION OF THE CYTOSOLIC CARBOXYLESTERASE CATALYZING THE 5′-DEOXY-5-FLUOROCYTIDINE FORMATION FROM CAPECITABINE IN HUMAN LIVER. Drug Metabolism and Disposition. 32(10). 1103–1110. 89 indexed citations
19.
Yamanaka, Hiroyuki, Miki Nakajima, Miki Katoh, et al.. (2004). A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity. Pharmacogenetics. 14(5). 329–332. 105 indexed citations
20.
Katoh, Miki, Miki Nakajima, Hiroshi Yamazaki, & Tsuyoshi Yokoi. (2001). Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport. European Journal of Pharmaceutical Sciences. 12(4). 505–513. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Andrew Williams Breakdown of academic impact, for papers by Chuang Lu Breakdown of academic impact, for papers by A. David Rodrigues Breakdown of academic impact, for papers by Jean‐Charles Gautier Breakdown of academic impact, for papers by Su Duan Breakdown of academic impact, for papers by Kazuhide Iwasaki Breakdown of academic impact, for papers by Michael Sinz Breakdown of academic impact, for papers by Zhi‐Rong Tan Breakdown of academic impact, for papers by Brahim Achour Breakdown of academic impact, for papers by Lydiane Pichard
Rankless by CCL
2026